Topical Antibiotic Regimen for Corneal Abrasion
For simple traumatic corneal abrasions, prescribe a broad-spectrum topical antibiotic such as a fluoroquinolone (e.g., moxifloxacin or gatifloxacin) or polymyxin B-trimethoprim 3-4 times daily until healed, typically 3-5 days. 1
Antibiotic Selection Algorithm
For Non-Contact Lens Related Abrasions:
- First-line options:
- Fluoroquinolones: Moxifloxacin 0.5% or gatifloxacin 0.3% (better gram-positive coverage) 1
- Alternative: Polymyxin B-trimethoprim or erythromycin ointment
- FDA-approved fluoroquinolones for bacterial keratitis include ciprofloxacin 0.3%, ofloxacin 0.3%, and levofloxacin 1.5%, though moxifloxacin and gatifloxacin perform equally well despite lacking FDA approval for this indication 1
For Contact Lens-Related Abrasions:
- Mandatory antipseudomonal coverage: Use fluoroquinolones (ciprofloxacin, ofloxacin, or levofloxacin) or aminoglycosides (tobramycin) 2, 3
- Critical caveat: Never patch or use therapeutic contact lenses in contact lens-related abrasions due to increased risk of bacterial keratitis 1
Dosing Strategy Based on Severity
Uncomplicated Small Abrasions (<4mm):
- Standard dosing: 3-4 times daily until epithelial healing (typically 24-48 hours)
- Ointment formulations acceptable at bedtime for less severe cases 1
Large or Central Abrasions (>2mm or involving visual axis):
- More frequent dosing: Every 1-2 hours while awake initially
- Consider fortified antibiotics if signs of infection develop 1
Critical Evidence Considerations
The 2024 Bacterial Keratitis Preferred Practice Pattern guidelines emphasize that prophylactic antibiotics should be started within 24 hours of abrasion to prevent ulceration 1. However, a 2025 Cochrane review found very low certainty evidence for antibiotic prophylaxis, with one study paradoxically showing increased infection risk with antibiotics versus placebo (RR 1.32) 4. Despite this equivocal research evidence, the guideline-based approach prioritizes infection prevention given the potentially devastating consequences of bacterial keratitis on vision.
Important Caveats
Resistance Patterns to Consider:
- 42% of Staphylococcal isolates show methicillin resistance with concurrent fluoroquinolone resistance 1
- Pseudomonas resistance to moxifloxacin has increased significantly in some regions (19% to 52% over 2 years) 1
- Fourth-generation fluoroquinolones (moxifloxacin, gatifloxacin) demonstrate superior gram-positive coverage compared to earlier generations 1
What NOT to Do:
- Avoid eye patching - does not improve pain and may delay healing 2
- Avoid therapeutic contact lenses in contact lens wearers due to infection risk 1
- Avoid ointments as monotherapy for significant abrasions - poor corneal penetration limits efficacy 1
Adjunctive Management
- Pain control: Topical NSAIDs (ketorolac, diclofenac) or oral analgesics 5, 2
- Cycloplegics: Consider for large/painful abrasions to reduce ciliary spasm, though evidence for routine use in uncomplicated abrasions is lacking 1, 2
- Avoid topical anesthetics for outpatient use - associated with 1.81-fold increased ED readmission risk and concerns for corneal toxicity 6